Profile
| Metric | Value |
|---|---|
| Full Name | Sonnet BioTherapeutics Holdings, Inc. |
| Ticker | NASDAQ: SONN |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | sonnetbio.com |
| Employees | 13 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $1.26 | |
| Price, 1D Change | - | |
| $8M | ||
| - | ||
| - | ||
| 1.10 | ||
| $1M | ||
| Revenue, 1Y Change | +5,276.34% | |
| -$3.95 | ||
| EPS, 1Y Change | +65.22% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:8 | |
| Next Split | N/A | N/A |
| Last Ticker Change | BURG | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$3.95 | ||
| EPS Estimate | N/A | - |
| EPS Est. Change | N/A | - |
| $1.00M | ||
| Revenue Estimate | N/A | - |
| Revenue Est. Change | N/A | - |
| Current Price | $1.26 | |
| Price Target | - | $20.00 |
| Price Tgt. Change | - | +1,487.30% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$17.42 | -$145.12 | -733.06% | |
| -$12.88 | -$11.35 | +11.88% | |
| -$3.46 | -$3.95 | -14.10% | |
| - | N/A | - |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $148.00K | $147.80K | -0.14% | |
| - | $18.60K | - | |
| $1.00M | $1.00M | 0.00% | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $1.26 | |
| $3.01 | ||
| SMA 200 vs Price | +139.06% | |
| $4.62 | ||
| SMA 50 vs Price | +266.37% | |
| 1.10 | ||
| $0.88 | ||
| 28.15 | ||
| 294.73% | ||
| 311.81% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $1.00M | ||
| -$3.95 | ||
| $910.70K | ||
| 91.07% | ||
| -$15.83M | ||
| -1,583.21% | ||
| -$16.01M | ||
| -1,601.15% | ||
| -$15.74M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.00 | ||
| 3.50 | ||
| 3.50 | ||
| - | ||
| - | ||
| -14.04 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 7.89 | ||
| 0.73 | ||
| 0.34 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $10.79M | ||
| $13.36M | ||
| $14.88M | ||
| $14.34M | ||
| $4.10M | ||
| $4.10M | ||
| $46.60K | ||
| $46.60K | ||
| $2.94M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $17.01M | ||
| $16.74M | ||
| $89.30K | ||
| $0.00 | ||
| $89.30K | ||
| $0.00 | ||
| $218.40K |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$12.83M | ||
| -$12.00K | ||
| $26.05M | ||
| $0.00 | ||
| -$12.83M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Chardan Capital | → | |
| Chardan Capital | → | |
| Chardan Capital | → | |
| Chardan Capital | → | |
| Chardan Capital | → | |
| EF Hutton | → | |
| Chardan Capital | → | |
| Ladenburg Thalmann | ||
| Chardan Capital | → | |
| EF Hutton | → |
Analyst sentiment
Institutional ownership
Screeners with SONN
Data Sources & References
- SONN Official Website www.sonnetbio.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1106838/000149315225027978/0001493152-25-027978-index.htm
- SONN Profile on Yahoo Finance finance.yahoo.com/quote/SONN
- SONN Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/sonn
FAQ
What is the ticker symbol for Sonnet BioTherapeutics Holdings, Inc.?
The ticker symbol for Sonnet BioTherapeutics Holdings, Inc. is NASDAQ:SONN
Does Sonnet BioTherapeutics Holdings, Inc. pay dividends?
No, Sonnet BioTherapeutics Holdings, Inc. does not pay dividends
What sector is Sonnet BioTherapeutics Holdings, Inc. in?
Sonnet BioTherapeutics Holdings, Inc. is in the Healthcare sector
What industry is Sonnet BioTherapeutics Holdings, Inc. in?
Sonnet BioTherapeutics Holdings, Inc. is in the Biotechnology industry
What country is Sonnet BioTherapeutics Holdings, Inc. based in?
Sonnet BioTherapeutics Holdings, Inc. is headquartered in United States
When did Sonnet BioTherapeutics Holdings, Inc. go public?
Sonnet BioTherapeutics Holdings, Inc. initial public offering (IPO) was on October 31, 2006
Is Sonnet BioTherapeutics Holdings, Inc. in the S&P 500?
No, Sonnet BioTherapeutics Holdings, Inc. is not included in the S&P 500 index
Is Sonnet BioTherapeutics Holdings, Inc. in the NASDAQ 100?
No, Sonnet BioTherapeutics Holdings, Inc. is not included in the NASDAQ 100 index
Is Sonnet BioTherapeutics Holdings, Inc. in the Dow Jones?
No, Sonnet BioTherapeutics Holdings, Inc. is not included in the Dow Jones index
When was Sonnet BioTherapeutics Holdings, Inc. last earnings report?
Sonnet BioTherapeutics Holdings, Inc.'s most recent earnings report was on December 17, 2025
When does Sonnet BioTherapeutics Holdings, Inc. report earnings?
The date for Sonnet BioTherapeutics Holdings, Inc.'s next earnings report has not been announced yet